The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 18, 2014
Filed:
Jun. 14, 2004
Applicant:
Gerald Horn, Deerfield, IL (US);
Inventor:
Gerald Horn, Deerfield, IL (US);
Assignee:
Ocularis Pharma, LLC, North Riverside, IL (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/74 (2006.01); A61K 31/517 (2006.01); A61K 31/4164 (2006.01); A61K 31/4745 (2006.01); A61K 31/496 (2006.01); A61K 31/66 (2006.01); A61K 31/00 (2006.01); A61K 31/138 (2006.01); A61K 31/417 (2006.01); A61K 31/475 (2006.01); A61K 31/4168 (2006.01); A61K 31/551 (2006.01); A61K 45/06 (2006.01); A61K 31/166 (2006.01); A61K 31/18 (2006.01);
U.S. Cl.
CPC ...
A61K 45/06 (2013.01); A61K 31/517 (2013.01); A61K 31/4164 (2013.01); A61K 31/4745 (2013.01); A61K 31/496 (2013.01); A61K 31/66 (2013.01); A61K 31/00 (2013.01); A61K 31/138 (2013.01); A61K 31/417 (2013.01); A61K 31/475 (2013.01); A61K 31/4168 (2013.01); A61K 31/551 (2013.01); A61K 31/166 (2013.01); A61K 31/18 (2013.01);
Abstract
Ophthalmic formulations are provided. The ophthalmic formulations include one or more active agents that act to optimize pupil light reflex while minimizing, or effectively eliminating, any undesired eye redness in response to application thereof. The active agents include, for example, alpha 1 antagonists, such as alpha 1a selective antagonists.